AVITA Medical, Inc.
RCEL
$4.08
$0.174.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.25M | 17.62M | 17.06M | 18.42M | 18.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.25M | 17.62M | 17.06M | 18.42M | 18.51M |
| Cost of Revenue | 3.52M | 3.30M | 3.19M | 3.47M | 2.83M |
| Gross Profit | 15.73M | 14.31M | 13.88M | 14.95M | 15.68M |
| SG&A Expenses | 18.90M | 19.03M | 19.28M | 20.98M | 21.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.05M | 28.02M | 26.22M | 29.57M | 30.34M |
| Operating Income | -8.80M | -10.41M | -9.15M | -11.15M | -11.83M |
| Income Before Tax | -10.62M | -11.64M | -13.17M | -9.92M | -13.85M |
| Income Tax Expenses | -11.00K | -17.00K | 15.00K | 4.00K | 8.00K |
| Earnings from Continuing Operations | -10.61M | -11.62M | -13.19M | -9.92M | -13.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.61M | -11.62M | -13.19M | -9.92M | -13.86M |
| EBIT | -8.80M | -10.41M | -9.15M | -11.15M | -11.83M |
| EBITDA | -8.18M | -9.76M | -8.58M | -10.60M | -11.31M |
| EPS Basic | -0.35 | -0.38 | -0.46 | -0.38 | -0.53 |
| Normalized Basic EPS | -0.21 | -0.23 | -0.27 | -0.21 | -0.31 |
| EPS Diluted | -0.35 | -0.38 | -0.46 | -0.38 | -0.53 |
| Normalized Diluted EPS | -0.21 | -0.23 | -0.27 | -0.21 | -0.31 |
| Average Basic Shares Outstanding | 30.54M | 30.38M | 28.39M | 26.37M | 26.25M |
| Average Diluted Shares Outstanding | 30.54M | 30.38M | 28.39M | 26.37M | 26.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |